1. Home
  2. SVRA vs BCAL Comparison

SVRA vs BCAL Comparison

Compare SVRA & BCAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • BCAL
  • Stock Information
  • Founded
  • SVRA 2007
  • BCAL 2001
  • Country
  • SVRA United States
  • BCAL United States
  • Employees
  • SVRA N/A
  • BCAL N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • BCAL Major Banks
  • Sector
  • SVRA Health Care
  • BCAL Finance
  • Exchange
  • SVRA Nasdaq
  • BCAL Nasdaq
  • Market Cap
  • SVRA 528.3M
  • BCAL 478.1M
  • IPO Year
  • SVRA N/A
  • BCAL N/A
  • Fundamental
  • Price
  • SVRA $2.28
  • BCAL $14.94
  • Analyst Decision
  • SVRA Buy
  • BCAL Strong Buy
  • Analyst Count
  • SVRA 7
  • BCAL 1
  • Target Price
  • SVRA $7.57
  • BCAL $20.00
  • AVG Volume (30 Days)
  • SVRA 2.5M
  • BCAL 81.1K
  • Earning Date
  • SVRA 05-13-2025
  • BCAL 07-28-2025
  • Dividend Yield
  • SVRA N/A
  • BCAL N/A
  • EPS Growth
  • SVRA N/A
  • BCAL N/A
  • EPS
  • SVRA N/A
  • BCAL 0.62
  • Revenue
  • SVRA N/A
  • BCAL $132,045,000.00
  • Revenue This Year
  • SVRA N/A
  • BCAL $74.16
  • Revenue Next Year
  • SVRA N/A
  • BCAL $4.92
  • P/E Ratio
  • SVRA N/A
  • BCAL $23.94
  • Revenue Growth
  • SVRA N/A
  • BCAL 42.63
  • 52 Week Low
  • SVRA $1.89
  • BCAL $11.87
  • 52 Week High
  • SVRA $5.11
  • BCAL $18.49
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 36.20
  • BCAL 55.07
  • Support Level
  • SVRA $1.89
  • BCAL $14.50
  • Resistance Level
  • SVRA $3.18
  • BCAL $15.27
  • Average True Range (ATR)
  • SVRA 0.21
  • BCAL 0.47
  • MACD
  • SVRA -0.11
  • BCAL -0.05
  • Stochastic Oscillator
  • SVRA 29.77
  • BCAL 39.64

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About BCAL Southern California Bancorp

California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank's solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through partnerships with its clients. The company has one operating segment: Commercial Banking.

Share on Social Networks: